CLINICAL_TRIALS
trial_result
· 2017-10-25
Clinical Trial Update: Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP) [Phase 4]
Summary
Phase 4 trial evaluating the timing of indomethacin to prevent post-ERCP pancreatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alberta | Conditions: Acute Pancreatitis | Phase 4 | Status: COMPLETED